» Articles » PMID: 28758408

Radiation Therapy for WHO Grade I Meningioma

Overview
Journal Chin Clin Oncol
Specialty Oncology
Date 2017 Aug 1
PMID 28758408
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Maximal safe resection has long been the cornerstone of treatment for WHO grade I benign meningioma. However, as technology for both imaging and radiation delivery has advanced, radiation therapy has played an increasingly important role in the management of patients with WHO grade I meningioma. Radiation therapy, whether delivered as standard fractionated treatment over several weeks, stereotactic radiosurgery over 1 session, or multisession stereotactic radiation therapy, has been shown to provide excellent local control when used as an adjunct to surgery or as primary treatment. Here, we review the indications for radiation therapy for patients with WHO grade I meningioma, as well as the various techniques that have been developed. We also review the toxicities and late effects associated with treatment.

Citing Articles

Simpson's Grading Scale for WHO Grade I Meningioma Resection in the Modern Neurosurgical Era: Are We Really Asking the Right Question?.

Dadario N, Sughrue M J Neurol Surg B Skull Base. 2024; 85(2):145-155.

PMID: 38449587 PMC: 10914467. DOI: 10.1055/a-2021-8852.


Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center.

Qiu X, Gao J, Hu J, Yang J, Hu W, Huang Q J Neurooncol. 2023; 165(2):241-250.

PMID: 37976030 DOI: 10.1007/s11060-023-04401-8.


Trends in the use of radiation for meningioma across the United States.

Matani H, Abel S, Yu A, Karlovits S, Wegner R Radiat Oncol J. 2022; 40(1):29-36.

PMID: 35368198 PMC: 8984135. DOI: 10.3857/roj.2021.00563.


The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.

Roehrkasse A, Peterson J, Fung K, Pelargos P, Dunn I Front Oncol. 2022; 12:846232.

PMID: 35299730 PMC: 8921552. DOI: 10.3389/fonc.2022.846232.


Consensus core clinical data elements for meningiomas (v2021.1).

Nassiri F, Wang J, Au K, Barnholtz-Sloan J, Jenkinson M, Drummond K Neuro Oncol. 2021; 24(5):683-693.

PMID: 34791428 PMC: 9071284. DOI: 10.1093/neuonc/noab259.